Covid beneficiary Velocity Clinical Research explores sale, L Catterton invests in Birkinstock, First-timer Twist joins SPAC game
New tech-focused SPAC Twist Capital is targeting $175 million and L Catterton backs Birkinstock.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
